Biologic degraders push forward in the clinic
Asher Mullard
Nature Reviews Drug Discovery, Published online: 20 April 2026; doi:10.1038/d41573-026-00064-y A handful of antibody-based extracellular targeted protein degraders are advancing in the clinic, highlighting emerging opportunities to destroy disease-linked proteins in cancer and autoimmunity.